News Ozempic Comes To India At Rs 2,200 Weekly Dose, Novo Nordisk Cautions Against Unsupervised Use Ozempic has been approved for type-2 diabetes, while Novo Nordisk’s other global blockbuster Wegovy is targeted at obesity. Post navigation Previous: 8 In 10 Airline Passengers Experienced ‘Dark Patterns’ In 1 year, Mostly On Indigo: SurveyNext: ‘Ready To Discuss, Find Solution’: Centre To Opposition’s Air Pollution Debate Demand In Lok Sabha More Stories News Opinion | Nitish Kumar’s Exit Marks The End Of The Mandal Era In Bihar News Over 5,100 Women Deployed At 1,140 National Highway Toll Plazas; More To Join: NHAI News RTI Says Telangana Govt Funded Revanth Reddy’s Harvard Course, Congress Rejects Claim